While systemic MPO levels have been associated with poor prognosis in acute CAD patients, studies have shown that elevated systemic MPO levels are linked to increased cardiovascular events, such as myocardial infarction, heart failure, and mortality, in patients with acute CAD [10, 19–21]. This evidence concerns the gene MPO and coronary artery disorder.